Published by Josh White on 17th April 2023
(Sharecast News) - Life science company Avacta Group announced the presentation of pre-clinical data for its novel 'preCISION' proteasome inhibitor AVA3996 on Monday.
URL: http://www.digitallook.com/dl/news/story/33438442/...